# Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder

> **NCT01008098** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 26 (estimated)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** escitalopram (lexapro)

## Key facts

- **NCT ID:** NCT01008098
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01008098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01008098, "Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01008098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*